Month: <span>February 2019</span>

Home / 2019 / February
Post

The growing role of precision and personalized medicine for cancer treatment

In a paper published in the September/December 2018 issue of TECHNOLOGY, a group of researchers from Rutgers University Department of Biomedicine Engineering have published a review paper on the transformative potential of precision and personalized medicine (PPM) for cancer treatment. IMAGE: TRADITIONAL VERSUS PPM MODEL FOR CANCER TREATMENT. A COMPARISON OF THE KEY DIFFERENCES IN THE...

Post

Middle-aged migraine sufferers who see flashing lights and blind spots during an attack are TWO times more likely to have a stroke

Over-50s who start having aura migraines have a doubled stroke risk But people who begin having migraines when younger do not have higher risk A study by the University of South Carolina tracked 11,600 people for 20 years Developing severe migraines in middle age is a major warning sign of stroke risk, experts have warned....

Post

Measles outbreak in Washington State

The latest update from the county’s health department said that 23 measles cases have been confirmed and two more suspected cases are under investigation, CBS News reported. Most cases involve children ages 1 to 10 years. Four cases are in youngsters ages 11 to 18, and one case is in a person between ages 19...

Post

Aspiring Dermatology App Under The Microscope: The SkinVision Review

With 1.2 million downloads globally and having helped diagnose the condition in over 27,000 cases, SkinVision aims to fight against one of the most deadly diseases, skin cancer. It usually manifests as seemingly harmless skin spots, called nevi, whose early detection and removal can literally save your life. That’s the promise of the dermatology app,...

Post

Levodopa + carbidopa does not modify disease in early Parkinson

Constant V.M. Verschuur, M.D., from Amsterdam Neuroscience, and colleagues randomly assigned patients with early Parkinson disease to receive either levodopa (three times per day) in combination with carbidopa for 80 weeks (early-start group) or placebo for 40 weeks followed by levodopa in combination with carbidopa for 40 weeks (delayed-start group; 222 and 223 patients, respectively)....

Post

Metabolomic Profiling for Disease Diagnosis

The Human Metabolome Database presently lists over 114,000 molecules. Each cell type, tissue or organ has a particular metabolomic fingerprint, unique due to the number and type of certain metabolites that are found there. Unexpected amounts or types of metabolites may imply a current or impending health issue. Christoph Burgstedt | Shutterstock While genomics and...

Post

New skin test detects prion infection before symptoms appear

Prions can infect both humans and animals, causing Creutzfeldt-Jakob disease (CJD) in humans, mad cow disease in cattle, and chronic wasting disease in elk and deer. The infectious, misfolded protein particles often go undetected as they destroy brain tissue, causing memory loss, mobility issues, and ultimately death. Preclinical detection of prions has proven difficult, but...

Post

Messages for increasing parental confidence in HPV vaccine ID’d

Parth D. Shah, Pharm.D., Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues surveyed a national sample of 1,196 U.S. parents of children aged 9 to 17 years in 2017 to 2018. The researchers recorded brief videos of a pediatrician providing messagesthat addressed seven HPV vaccination topics that often elicit questions or...